Under construction – not a live service
Sign in
Taking people in DenmarkNo phase

Comparing two keyhole surgery methods for early lung cancer removal

Compares robotic and video-assisted keyhole surgery to remove early lung cancer.

Plain-language title generated from the registry record
Registry title: Lung cAncer Robotic Comparative Study

Key facts

Where
Copenhagen, DenmarkSee the site

Where in Denmark

  • Copenhagen University Hospital, RigshospitaletCopenhagen, DenmarkTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Intuitive Surgical
Trial code
NCT06038227
Record updated
14 September 2026
Original description
To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.Read full original descriptionShow less

Comparing Outcomes for Minimally Invasive Techniques for Anatomic Lung Resection for Cancer - A Prospective, Comparative, Non-randomized, Open Label Post-market Observational Cohort Study Within Europe

To compare outcomes of minimally invasive surgical techniques for the treatment of early-stage non-small cell lung cancer.

Inclusion: Patient diagnosed with clinical stage IA1-2 non-small cell lung cancer at time of procedure; Patient scheduled to undergo minimally invasive surgery for NSCLC with either da Vinci robotic assisted surgery or VATs; Aged ≥ 18 years; Must be willing and able to comply with study requirements; Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form.

Exclusion: Patient receiving a lobectomy/segmentectomy as an emergency procedure; Patients receiving a lobectomy/segmentectomy for metastatic cancer; Patients with clinical stage IA3, II, III, and IV lung cancer; Patients scheduled to receive a bilobectomy or sleeve-lobectomy; Mental incapacity to understand or consent to study procedures; Anticipated difficulty for patient to comply with protocol requirements; Unable to comply with the follow up schedule; Pregnant or are planning to become pregnant during the study; Life expectancy < 12 months.

ClinicalTrials.gov NCT06038227